cure

Cure ? Sonneveld et al (2013) J Clin Oncol 31(26): 3279-87 - PowerPoint PPT Presentation

May 29, 2023 •173 likes •447 views

Cure ? Sonneveld et al (2013) J Clin Oncol 31(26): 3279-87

  3. Cure ?

  6. • •

  10. • Sonneveld et al (2013) J Clin Oncol 31(26): 3279-87

  12. •

  13. • •

  20.   

  21.    

  25. • • • • •

Recommend

Feeling right at home Getting to Cure From Cure to Eradication Jordan J. Feld MD MPH Toronto

Feeling right at home Getting to Cure From Cure to Eradication Jordan J. Feld MD MPH Toronto

Feeling right at home Getting to Cure From Cure to Eradication Jordan J. Feld MD MPH Toronto Centre for Liver Disease Sandra Rotman Centre for Global Health University of Toronto Dramatic Improvements DAAs 2014 PR + NI 95-99% 2013 100%

997 views • 52 slides
Vaccinosis and Its Cure by Thuja by J. Compton Burnett written in the 1800s first printed in

Vaccinosis and Its Cure by Thuja by J. Compton Burnett written in the 1800s first printed in

Vaccinosis and Its Cure by Thuja by J. Compton Burnett written in the 1800s first printed in 1897. Lets take a look at what he knew in the 1880s and what we know now today in 2011. Page 9 Vaccinosis baring the way to a cure of an

380 views • 20 slides
IN INRA (F (Fran ance) e) CURE-XF Kick-off Meeting CIHEAM Bari 28-29 September, 2017 INRA :

IN INRA (F (Fran ance) e) CURE-XF Kick-off Meeting CIHEAM Bari 28-29 September, 2017 INRA :

H2020-MSCA-RISE-2016 Funded by the European Union CURE-XF - 734353 Pr Presentation of Pa Partner 5 IN INRA (F (Fran ance) e) CURE-XF Kick-off Meeting CIHEAM Bari 28-29 September, 2017 INRA : H2020-MSCA-RISE-2016 Funded by the European

472 views • 15 slides
Chimeric Antigen Receptor (CAR) T Cell Therapy: A Cure for Cancer? Michael R. Bishop, M.D.

Chimeric Antigen Receptor (CAR) T Cell Therapy: A Cure for Cancer? Michael R. Bishop, M.D.

Chimeric Antigen Receptor (CAR) T Cell Therapy: A Cure for Cancer? Michael R. Bishop, M.D. Director, Cellular Therapy Program University of Chicago CAR T Cell Therapy: A Cure for Cancer? Disclosures Honoraria: Celgene, OptumHealth,

655 views • 50 slides
Towards the Goal of a Cure for Multiple Myeloma The Partnership of the DGMRF and DFCI Successes

Towards the Goal of a Cure for Multiple Myeloma The Partnership of the DGMRF and DFCI Successes

Towards the Goal of a Cure for Multiple Myeloma The Partnership of the DGMRF and DFCI Successes of the First Phase and Driving Towards a Cure in the Second Phase Paul Richardson, MD Corman Professor of Medicine Constantine S. Mitsiades, MD,

389 views • 18 slides
RESIDUAL STRAIN MEASUREMENT IN Presentation by: Jason Cantrell COMPOSITES USING CURE-

RESIDUAL STRAIN MEASUREMENT IN Presentation by: Jason Cantrell COMPOSITES USING CURE-

RESIDUAL STRAIN MEASUREMENT IN Presentation by: Jason Cantrell COMPOSITES USING CURE- COMPOSITES USING CURE EAS 6939 1/31/11 REFERENCING METHOD by: P.G Ifju, X. Niu, B.C Kilday, S.-C. Liu & S.M. Ettinger Background g Residual

419 views • 12 slides
Successes of the 1 st phase Going for a cure in Phase II September 2019 TABLE OF

Successes of the 1 st phase Going for a cure in Phase II September 2019 TABLE OF

Finding a Cure for Multiple Myeloma Successes of the 1 st phase Going for a cure in Phase II September 2019 TABLE OF CONTENTS Letter from the President............................................................................... 3

650 views • 41 slides
P11 BPI H2020-MSCA-RISE-2016 Funded by the European Union CURE-XF - 734353 BENAKI

P11 BPI H2020-MSCA-RISE-2016 Funded by the European Union CURE-XF - 734353 BENAKI

Pr Presentation of Pa Partners P11 BPI H2020-MSCA-RISE-2016 Funded by the European Union CURE-XF - 734353 BENAKI PHYTOPATHOLOGICAL INSTITUTE CURE-XF Kick-off Meeting CIHEAM Bari 28-29 September, 2017 BENAKI PHYTOPATHOLOGICAL INSTITUTE

432 views • 10 slides
Consejo Superior de Investigaciones Cientficas (CSIC) Spain, P6 CURE-XF Kick-off Meeting

Consejo Superior de Investigaciones Cientficas (CSIC) Spain, P6 CURE-XF Kick-off Meeting

H2020-MSCA-RISE-2016 Funded by the European Union CURE-XF - 734353 Consejo Superior de Investigaciones Cientficas (CSIC) Spain, P6 CURE-XF Kick-off Meeting CIHEAM Bari 28-29 September, 2017 H2020-MSCA-RISE-2016 Funded by the European Union

259 views • 14 slides
Universit catholique de Louvain H2020-MSCA-RISE-2016 Funded by the European Union CURE-XF -

Universit catholique de Louvain H2020-MSCA-RISE-2016 Funded by the European Union CURE-XF -

Universit catholique de Louvain H2020-MSCA-RISE-2016 Funded by the European Union CURE-XF - 734353 Earth&Life Institute Plant Pathology Lab Pr Presentatio ion o of Pa Partners P UCL UCL CURE-XF Kick-off Meeting CIHEAM Bari

368 views • 8 slides
Institut National de la CURE-XF - 734353 Recherche Pr Presentation of Pa Partners P1 P19 -

Institut National de la CURE-XF - 734353 Recherche Pr Presentation of Pa Partners P1 P19 -

H2020-MSCA-RISE-2016 Funded by the European Union Institut National de la CURE-XF - 734353 Recherche Pr Presentation of Pa Partners P1 P19 - IN INRA Maroc CURE-XF Kick-off Meeting CIHEAM Bari 28-29 September, 2017 Institut National de

275 views • 9 slides
EPISTEM European Project to guide and investigate the potential for HIV cure by Stem Cell

EPISTEM European Project to guide and investigate the potential for HIV cure by Stem Cell

EPISTEM European Project to guide and investigate the potential for HIV cure by Stem Cell Transplantation. www.epistem-project.org EPISTEM Project to guide and investigate the potential for HIV cure in HIV-infected patients requiring

293 views • 8 slides
Patient Outcome? 2 Patient outcome Mitigate or cure disease No effect Adverse

Patient Outcome? 2 Patient outcome Mitigate or cure disease No effect Adverse

D I S E A S E Patient Outcome? 2 Patient outcome Mitigate or cure disease No effect Adverse drug event, difficult to predict Sometimes serious 3 Pharmacogenomic Medical Paradigm Patient Outcome - Mitigate or cure

999 views • 42 slides
Lung Cancer : Lung Cancer : Lung Cancer : Lung Cancer : Improving the Cure Rate Improving the

Lung Cancer : Lung Cancer : Lung Cancer : Lung Cancer : Improving the Cure Rate Improving the

Lung Cancer : Lung Cancer : Lung Cancer : Lung Cancer : Improving the Cure Rate Improving the Cure Rate with Radiation with Radiation ith R di ti ith R di ti Andrea Andrea Bezjak Bezjak , MDCM, MSc, FRCPC The Addie MacNaughton Chair in

649 views • 54 slides
Understanding new medicines to treat chronic hepatitis B: toward a cure October 26, 2016 Define

Understanding new medicines to treat chronic hepatitis B: toward a cure October 26, 2016 Define

Understanding new medicines to treat chronic hepatitis B: toward a cure October 26, 2016 Define an HBV cure Functionally (practical): Sustained, off drug response (loss of viremia and antigenemia Clinically: Return an individual to the

625 views • 33 slides
The Cure-Death Model A new approach for a randomised clinical trial design to increase efficiency

The Cure-Death Model A new approach for a randomised clinical trial design to increase efficiency

Introduction Mathematical Background The Cure-Death Model Application Discussion and Future Work The Cure-Death Model A new approach for a randomised clinical trial design to increase efficiency of clinical endpoint evaluations ISCB 2015

357 views • 19 slides
Play2 Non blocking, composable reactive web programming with Iteratees and Promises in Play2

Play2 Non blocking, composable reactive web programming with Iteratees and Promises in Play2

Play2 Non blocking, composable reactive web programming with Iteratees and Promises in Play2 Monday, June 18, 12 @sadache @hguergachi @guillaumebort Monday, June 18, 12 www.zenexity.com Web Oriented Architectures Monday, June 18, 12 What

399 views • 27 slides
Dual Approximate Dynamic Programming for Large Scale Hydro Valleys P. Carpentier, J-P.

Dual Approximate Dynamic Programming for Large Scale Hydro Valleys P. Carpentier, J-P.

Dams management problem DADP in a nutshell Numerical experiments Dual Approximate Dynamic Programming for Large Scale Hydro Valleys P. Carpentier, J-P. Chancelier, V. Lecl` ere, F. Pacaud supported by the FMJH Program Gaspard Monge for

883 views • 33 slides
Application Architectures Sommerville, Chapters 13, 16 Instructor: Peter Baumann email:

Application Architectures Sommerville, Chapters 13, 16 Instructor: Peter Baumann email:

Application Architectures Sommerville, Chapters 13, 16 Instructor: Peter Baumann email: p.baumann@jacobs-university.de tel: -3178 office: room 88, Research 1 Backup not found: (A)bort (R)etry (P)anic 320312 Software Engineering (P.

268 views • 6 slides
Ill see your async and raise you reactive @sadache @guillaumebort @zenexity What is Play?

Ill see your async and raise you reactive @sadache @guillaumebort @zenexity What is Play?

Ill see your async and raise you reactive @sadache @guillaumebort @zenexity What is Play? The Play framework makes it easier to build web applications with Java & Scala. Play is based on a lightweight, stateless, web- friendly

618 views • 36 slides
Low-energy local density of states of the 1D Hubbard model Imke Schneider, Institut fr

Low-energy local density of states of the 1D Hubbard model Imke Schneider, Institut fr

Low-energy local density of states of the 1D Hubbard model Imke Schneider, Institut fr Theoretische Physik, TU Dresden Florence, 30th May 2012 In collaboration with: Stefan Sffing, Michael Bortz, Alexander Struck, and Sebastian Eggert, TU

497 views • 24 slides
Harmonic measure, Riesz transforms, and uniform rectifiability Xavier Tolsa 12 May 2017 X.

Harmonic measure, Riesz transforms, and uniform rectifiability Xavier Tolsa 12 May 2017 X.

Harmonic measure, Riesz transforms, and uniform rectifiability Xavier Tolsa 12 May 2017 X. Tolsa (ICREA / UAB) Harmonic measure, Riesz transforms, and rectifiability 12 May 2017 1 / 19 Rectifiability We say that E R d is rectifiable if

1.06k views • 64 slides
Multicriteria optimization of molecular force field models M. T. Horsch, 1 K. Stbener, 1, 2 S.

Multicriteria optimization of molecular force field models M. T. Horsch, 1 K. Stbener, 1, 2 S.

Multicriteria optimization of molecular force field models M. T. Horsch, 1 K. Stbener, 1, 2 S. Werth, 1 J. Vrabec, 3 and H. Hasse 1 1 Laboratory of Engineering Thermodynamics, University of Kaiserslautern, Germany 2 Fraunhofer Institute for

480 views • 20 slides
Multicriteria optimization of force field models for molecular simulation of interfacial and bulk

Multicriteria optimization of force field models for molecular simulation of interfacial and bulk

Multicriteria optimization of force field models for molecular simulation of interfacial and bulk properties Martin Thomas Horsch, 1, 2 Stephan Werth, 1 Katrin Stbener, 1, 3 Peter Klein, 3 Karl-Heinz Kfer, 3 and Hans Hasse 1 1 Laboratory of

440 views • 17 slides

More recommend